ESSA Pharma Inc.
EPIX
$1.74
$0.021.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.05% | -15.94% | 0.89% | -27.33% | 11.53% |
| Total Depreciation and Amortization | 1.74% | -16.18% | -25.33% | -26.97% | -24.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,176.39% | 261.50% | 148.78% | -11.70% | -86.38% |
| Change in Net Operating Assets | 61.47% | 28.65% | -140.58% | 376.06% | -211.27% |
| Cash from Operations | 4.67% | 25.00% | -17.11% | -13.43% | -55.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -147.72% | 8,045.73% | 102.64% | 7,225.95% | 650.96% |
| Cash from Investing | -147.72% | 8,045.73% | 102.64% | 7,225.95% | 650.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 224.46% | -- | -- | 291.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 538.97% | 172.11% | 1,960.12% | 1,152.87% |
| Foreign Exchange rate Adjustments | -- | 306.25% | -35.71% | 57.69% | 200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -733.06% | 471.96% | 2.33% | 914.15% | 128.05% |